Citadel Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Citadel Advisors’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,500	Closed	-$2.21K	–	15460
2023 Q2	$2.21K	Sell	4,500 -4,900	-52%	-$4.01K	﹤0.01%	13811
2023 Q1	$10.9K	Buy	9,400 +2,900	+45%	+$5.3K	﹤0.01%	13497
2022 Q4	$17.4K	Sell	6,500 -5,800	-47%	-$15.3K	﹤0.01%	13248
2022 Q3	$35K	Sell	12,300 -8,000	-39%	-$34K	﹤0.01%	11831
2022 Q2	$101K	Sell	20,300 -13,000	-39%	-$68.1K	﹤0.01%	11408
2022 Q1	$237K	Sell	33,300 -10,000	-23%	-$82.7K	﹤0.01%	11133
2021 Q4	$787K	Sell	43,300 -10,300	-19%	-$222K	﹤0.01%	8536
2021 Q3	$1.05M	Buy	53,600 +24,000	+81%	+$913K	﹤0.01%	8036
2021 Q2	$1.33M	Sell	29,600 -22,100	-43%	-$1.02M	﹤0.01%	7611
2021 Q1	$2.6M	Buy	51,700 +28,100	+119%	+$1.92M	﹤0.01%	5781
2020 Q4	$2.11M	Buy	+23,600	New	+$1.99M	﹤0.01%	5253

Other funds holding CELL

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's CELL Position: Q2 2023 in Review

Citadel Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 67,104 shares — an estimated $54.9K sold.

Citadel Advisors first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $12M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

Citadel Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 67,104 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $54.9K.
Citadel Advisors first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
Citadel Advisors's PhenomeX Inc. Common Stock position peaked at $12M in Q1 2021.
84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.